| Financial Year |
March 31 2023 |
| Monetary Funds |
101,721,940.14 |
| Held-for-trading Financial Assets |
205,791,244.70 |
| Notes Receivable |
-- |
| Accounts Receivable |
106,998,868.23 |
| Advances to Suppliers |
88,508,587.07 |
| Other Receivables |
28,304,351.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,489,784.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
295,082.04 |
| Total Current Assets |
533,109,858.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,693,772.61 |
| Investment Properties |
161,225,833.81 |
| Fixed Assetes |
6,498,274.79 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,151,432.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
686,153.01 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
177,255,466.64 |
| Total Assets |
710,365,325.09 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
43,520,598.66 |
| Accounts Received In Advance |
3,947,526.95 |
| Employee Compensation Payable |
28,154,177.96 |
| Taxes Payable |
1,866,418.17 |
| Interest Payable |
-- |
| Dividend Payable |
716,561.13 |
| Other payables |
47,485,390.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,215,816.00 |
| Other Current Liabilities |
1,005,028.92 |
| Sub-Total of Current Liabilities |
249,639,671.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,013,100.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,562,606.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,741,414.75 |
| Total Liabilities |
282,381,086.65 |
| Paid-In Capital(Or Share Stock) |
200,991,343.00 |
| Capital Surplus |
211,783,201.47 |
| Surplus Reserve |
43,389,742.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-28,915,782.48 |
| Minority Stockholder's Interest |
-264,266.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
428,248,504.81 |
| Owner's Equity（Stockholder's Equity） |
427,984,238.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
710,365,325.09 |
